About

Letters from the Director: A New Plan to End the HIV Epidemic in the United States

During the State of the Union Address in February 2019, the President announced the administration’s ambitious goal to end the HIV epidemic in the United States by 2030. Nearly four decades of investments in scientific research have yielded prevention and treatment breakthroughs that now make it possible to control HIV infection. A coordinated effort across government agencies promises to provide additional expertise, technology, and resources where they are needed most. The U.S.

Read more about Letters from the Director: A New Plan to End the HIV Epidemic in the United States

Letters from the Director: FY 2020 NIH HIV/AIDS Professional Judgment Budget― The Next Frontiers in HIV Research

Cover image of FY 2020 Professional Judgement Budget Each year the NIH Office of AIDS Research (OAR) releases a Professional Judgment Budget that estimates the funds needed to develop existing or pursue new scientific opportunities in HIV prevention, treatment, and cure research.

Read more about Letters from the Director: FY 2020 NIH HIV/AIDS Professional Judgment Budget― The Next Frontiers in HIV Research

Letters from the Director: Request for Information: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

The OAR is soliciting feedback from its stakeholder communities on the NIH HIV Research Priorities and Guidelines for Determining HIV Funding as a flexible, dynamic, comprehensive framework to guide the use of HIV-designated funding for fiscal years 2021 through 2025. Stakeholder comments about the NIH HIV Research Priorities will provide valuable information for use in advancing the NIH HIV research agenda and for developing the NIH Strategic Plan for HIV and HIV-related Research for fiscal years 2021 through 2025.

Read more about Letters from the Director: Request for Information: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

Letters from the Director: Focus on Prevention: Reflections from HIVR4P

Greetings! I recently returned from Madrid, Spain where Dr. Paul Gaist of the OAR and I attended the HIV Research for Prevention (HIVR4P) 2018 conference. It is the only global conference that focuses on biomedical HIV prevention research and provides a venue for connecting with other HIV prevention experts.

Read more about Letters from the Director: Focus on Prevention: Reflections from HIVR4P

Letters from the Director: USCA Reflections “Fight Back! Fight HIV!”

Titled “Fight Back! Fight HIV!” this year’s 22nd United States Conference on AIDS (USCA) presented an opportunity to highlight remarkable successes in our almost 40-year quest to reach an AIDS-free generation, and to share the latest research and treatment progress on topics such as perinatal infection, youth and adolescents with HIV, new technologies in drug development and drug discovery, and new trends tied to the opioid crisis.

Read more about Letters from the Director: USCA Reflections “Fight Back! Fight HIV!”

Letters from the Director: Fiscal Year (FY) 2019/2020 NIH Strategic Plan for HIV and HIV-Related Research

The NIH Office of AIDS Research (OAR) recently released the FY 2019/2020 NIH Strategic Plan for HIV and HIV-Related Research. The Plan was developed in consultation with a broad network of HIV research stakeholders, including NIH and extramural scientific experts, advisory committee members, community representatives, and people with HIV.

Read more about Letters from the Director: Fiscal Year (FY) 2019/2020 NIH Strategic Plan for HIV and HIV-Related Research

Reflections from the International AIDS Society Conference

The 2018 International AIDS Society Conference (IAS) provided the ideal platform to check our progress toward ending the HIV/AIDS pandemic. This year, we felt a shared urgency with our global partners to move quicker and smarter toward our mutual goal.